Aura Biosciences (NASDAQ: AURA) director receives RSUs and 30,000 stock options

Rhea-AI Filing Summary

Aura Biosciences director Sapna Srivastava received new equity awards in the form of stock and options. She was granted 15,000 shares of Common Stock through a restricted stock unit (RSU) award and 30,000 stock options with an exercise price of $6.21 per share.

The RSUs and options each vest in full on the earlier of June 11, 2027 or the company’s next annual stockholder meeting, subject to her continued service. After the RSU grant, her direct Common Stock holdings total 38,500 shares, and she holds 30,000 options to buy additional shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Srivastava Sapna

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	30,000	$0.00	--
Grant/Award	Common Stock	15,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 30,000 shares (Direct, null); Common Stock — 38,500 shares (Direct, null)

Footnotes (1)

1. These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Key Figures

RSU grant: 15,000 shares Stock options granted: 30,000 options Option exercise price: $6.21 per share +3 more

6 metrics

RSU grant 15,000 shares Restricted stock units granted to director on June 11, 2026

Stock options granted 30,000 options Options on Common Stock granted on June 11, 2026

Option exercise price $6.21 per share Strike price for 30,000 stock options

Shares after RSU grant 38,500 shares Total direct Common Stock held following RSU award

Option expiration date June 11, 2036 Expiration of 30,000 stock options

Vesting date trigger Earlier of June 11, 2027 or next annual meeting Vesting condition for RSUs and options

Key Terms

restricted stock unit, RSU, 2021 Stock Option and Incentive Plan, stock option, +1 more

5 terms

restricted stock unit financial

"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU financial

"Each RSU represents the right to receive one share of the Issuer's Common Stock."

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

2021 Stock Option and Incentive Plan financial

"These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan."

stock option financial

"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting..."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Common Stock financial

"Each RSU represents the right to receive one share of the Issuer's Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Srivastava Sapna

(Last) (First) (Middle)

C/O AURA BIOSCIENCES, INC.

80 GUEST STREET

(Street)

BOSTON MASSACHUSETTS 02135

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aura Biosciences, Inc. [ AURA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		15,000(1)	A	$0	38,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.21	06/11/2026		A		30,000		(2)	06/11/2036	Common Stock	30,000	$0	30,000	D

Explanation of Responses:

1. These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

2. This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

	/s/ Conor Kilroy, as Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Aura Biosciences (AURA) director Sapna Srivastava report on this Form 4?

She reported receiving equity compensation: 15,000 restricted stock units and 30,000 stock options. Both awards relate to Aura Biosciences Common Stock and were granted without a cash purchase, reflecting routine director compensation rather than an open-market stock transaction.

How many Aura Biosciences (AURA) shares does Sapna Srivastava hold after these grants?

Following the RSU grant, she directly holds 38,500 shares of Common Stock. In addition, she has 30,000 stock options that, once vested and exercised, would allow her to acquire more shares at the stated exercise price.

What are the terms of the 15,000 RSUs granted to Sapna Srivastava at Aura Biosciences (AURA)?

The 15,000 RSUs each represent one share of Common Stock and were granted under Aura’s 2021 Stock Option and Incentive Plan. They vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting, assuming her continued service.

What are the key details of the 30,000 stock options granted to Sapna Srivastava at Aura Biosciences (AURA)?

She received 30,000 stock options to purchase Common Stock at an exercise price of $6.21 per share. These options vest in full on the earlier of June 11, 2027 or the next annual stockholder meeting and expire on June 11, 2036.

Were Sapna Srivastava’s Aura Biosciences (AURA) Form 4 transactions open-market buys or sales?

No. The filing shows grant or award acquisitions coded as “A,” not open-market purchases or sales. She received RSUs and stock options as compensation, with no reported market trading activity in the company’s shares in this Form 4.

Under which plan were the Aura Biosciences (AURA) RSUs granted to Sapna Srivastava?

The 15,000 RSUs were granted under Aura Biosciences’ 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of Common Stock, subject to the specified vesting conditions and her continued service with the company.